New York Professional Events List


Data Integrity: FDA/EU Requirements and Implementation


Date
Oct 14, 2021 - 09:00 AM - Oct 15, 09:00 AM
Organizer
Global Compliance Panel
Location
Courtyard by Marriott Arlington Crystal City/Reagan National Airport 2899 Jefferson Davis Hwy, Arlington, VA 22202, USA,

Arlington,
VA,
US,
ZIP: 22202
Phone: 1 929 900 1853

There is no doubt that data integrity is the current and future inspection focus of all regulatory health care agencies. More than 50% inspection reports such as 483's and Warning Letters quote data integrity as deviations from GxP regulations.

This new two-day course provides the regulatory background and guides attendees through the complete record lifecycle from data entry or acquisition through evaluation, reporting, archiving and retrieval. It also helps to fully understand not only the text but also the meaning of related regulations such as FDA's Part 11 and the EU/PICS Annex 11.

This two-day course not only ensures a full understanding of the regulations and guidelines for raw data and other records but also provides templates and examples to develop inspection ready documentation. Interactive exercises will be dispersed into and between the presentations. About 50% of the total time will be dedicated to practical sessions. Here attendees work in small groups on case studies and prepare the answers using prepared fill-in templates. After the course a large variety of tools such as SOPs, validation examples and checklists will be readily available on a dedicated website that can be used to easily implement what they have learned in the course.

Learning Objectives:

  • Understand what data integrity is and why it is so important for public health
  • Learn why there are so many data integrity issues
  • Learn about the FDA/EU/PICS/MHRA/WHO requirements for data integrity
  • Understand how to define and archive raw data from hybrid systems: electronic vs. paper
  • Be able to specify and validate Part 11 compliant software functionality
  • Learn how to ensure and document integrity of raw data and other records according to Part 11 and Annex 11
  • Understand FDA's New and ongoing Part 11 inspection and enforcement practices
  • Learn how to develop and implement corrective and preventive action plans in response to inspection reports
  • Learn how to avoid and/or respond to FDA inspectional observations and warning letters
  • Learn how to prevent and detect data integrity issues

Who Will Benefit:

  • QA managers and personnel
  • Laboratory managers and supervisors
  • Production managers and supervisors
  • Analysts
  • IT/IS managers and system administrators
  • Software developers
  • Regulatory affairs
  • Training departments
  • Documentation departments
  • Consultants
---------------------------------------------------------------------
Please contact the event manager Marilyn below for the following:
- For Registrations Please call +1 929.900.1853
- Discounts for registering 5 or more participants.
- If you company requires a price quotation.
Event Manager Contact: marilyn.b.turner(at)nyeventslist.com
You can also contact us if you require a visa invitation letter, after ticket purchase.
We can also provide a certificate of completion for this event if required.
 
NO REFUNDS OR TRANSFER ALLOWED ON REGISTRATIONS
-----------------------------------------------------------------
This Event Listing is Promoted by
New York Media Technologies LLC in association
with NetZealous LLC.

http://www.NyEventsList.com
http://www.BostonEventsList.com
http://www.SFBayEventsList.com
-----------------------------------------------------------------
JAI170516EVZTODAY

 


Agenda


Day 1 Schedule

Lectures and Workshop Exercises

Lecture 1:
Definitions, requirements and approaches for data integrity
Definition of data integrity: ALCOA+
The importance of data integrity for public health
Main reasons for non-compliance
Regulations and guidelines
FDA's inspection and enforcement strategy of Part 11
Lessons from recent FDA Warning Letters and how to avoid them

Lecture 2:
Introduction to FDA 21 CFR Part 11 and EU/PICS Annex 11
Objective, scope, current situation and future of Part11
Requirements for electronic records
Requirements for electronic and digital signatures
Additional requirements from the PICS/EU Annex 11,
Developing a gap analysis
Upgrading existing or purchasing new systems:
Six steps for implementation of Part11/Annex 11

Lecture 3:
Strategies to detect and avoid integrity issues
Recruit, train and retain employees who will be responsible for ensuring data integrity
Preventing data integrity issues: Going through details of ALCOA+
Possible causes for data integrity breaches
Understand system vulnerabilities, motivation and likelihood operators might compromise data
Understand the company's quality culture
Understand high risks in the data lifecycle
Learning from internal audits and FDA inspections

Lecture 4:
The Quality System as Prerequisite for Data Integrity
Contributing factors to poor quality
Consequences of poor quality systems
Recommendations from the FDA
Developing a Quality Culture
ICH Q10 - The quality system for pharma industry
Implementing key requirements: e.g., CAPA system, failure investigations, training, audits
Assessment of data integrity risks
Steps for on-going improvement
Day 2 Schedule

Lectures and Workshop Exercises

Lecture 5:
Cost effective Validation of software and computer systems
Selecting the right validation lifecycle model
Going through examples of a complete computer system validation from beginning to end
How risk assessments can help to determine the type and extent of validation
Defining user requirements based on risk
Vendor assessment and supplier agreements
Testing and documenting installation
Going through examples for OQ and PQ testing
Maintaining the validated state

Lecture 6:
Definition and Handling of Raw Data
Definition of Raw Data
Examples of raw data
Raw data for paper based and electronic systems
Criteria for electronic raw data with paper print-outs
Raw data management along the data lifecycle
Changing of raw data
Archiving of raw data from electronic and hybrid systems
Going through examples

Lecture 7:
Good documentation practices to ensure data integrity
Requirements for documentation ( ALCOA+)
Documents that must be readily available
Examples for good and bad documentation
Good practices for paper and electronic data
How to avoid common documentation mistakes
The importance of global documentation
Examples

Lecture 8:
Data Integrity Auditing: Internal and FDA inspections
Going through a typical FDA inspection as a model for internal audit
FDA's new approaches to data integrity inspections
Typical audit questions
Identifying systems that must be audited based on risk
Typical audit findings
The importance of the exit meeting
Writing a corrective and preventive action plan to fix data integrity audit findings
 

 


Speaker Details


Dr. Ludwig Huber

Chief Advisor - Global FDA compliance, Labcompliance
 
  • Chairman, presenter and panel discussion member at US-FDA Industry Training sessions and conferences
  • Served as team member of PDA's task forces "21 CFR Part 11", of US-FDA internal documents, and of the GAMP® special interest group on Laboratory Systems.
  • Presenter of the Year of the Institute for Validation and Technology
  • Director and chief editor of www.labcompliance.com, the global on-line resource for validation and compliance issues for laboratories.
  • Author of the books "Validation and Qualification in Analytical Laboratories, and "Validation of Computerized Analytical and Networked Systems"

Event Categories
BUSINESS & MANAGEMENT CONFERENCES
,
COMPUTERS AND INTERNET CONFERENCES
,
Finance
,
Technology
Keywords: fun, Fun , Health , implement, learn, Learning , purchase, sing, software , tools




Comments








Events Calendar

SunMonTueWedThuFriSat
26 27 28 29 30 1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31 1 2 3 4 5 6

Newsletters

VIP Life Time Subscription to our Newsletters!
$399.99
$299.99